Department of Physical Medicine & Rehabilitation and.
Pediatrics. 2014 Apr;133(4):643-50. doi: 10.1542/peds.2013-3195. Epub 2014 Mar 10.
A minority of pediatric patients who have mild traumatic brain injury (mTBI) report persistent postconcussive symptoms. In adults, failure on validity tests, which help to detect exaggerated or feigned problems, is associated with symptom complaints. No pediatric studies have examined the relationship between validity test performance and symptom report. We hypothesized that children failing a validity test would report significantly more postconcussive symptoms than those passing.
Using a consecutive clinical case series design, we examined 191 patients aged 8 to 17 years seen for neuropsychological evaluation after mTBI. Participants were administered a validity test (Medical Symptom Validity Test; MSVT) and completed a graded symptom scale as part of a neuropsychological battery.
A total of 23 participants (12%) failed the MSVT. The Fail group endorsed significantly more postconcussive symptoms than the Pass group, with a large effect size (P < .001; d = 1.1). MSVT performance remained a robust unique predictor of symptom report even after controlling for other influential factors (eg, female gender, premorbid psychiatric problems).
A subset of children who had persistent complaints after mTBI may be exaggerating or feigning symptoms. If such negative response bias remains undetected, errors in etiologic statements and less than optimal treatment may occur. Because the detection of invalid responding is well established in neuropsychology, clinical neuropsychologists should be incorporated routinely into clinical care for patients who have persistent complaints. To better control for noninjury effects in future pediatric mTBI studies, researchers should add validity tests to neurobehavioral outcome batteries.
少数患有轻度创伤性脑损伤(mTBI)的儿科患者报告存在持续性脑震荡后症状。在成年人中,有效性测试失败与症状主诉相关,该测试有助于发现夸大或伪装的问题。没有儿科研究检查过有效性测试表现与症状报告之间的关系。我们假设,在有效性测试中失败的儿童会比通过测试的儿童报告更多的脑震荡后症状。
我们使用连续的临床病例系列设计,检查了 191 名年龄在 8 至 17 岁之间的 mTBI 后接受神经心理评估的患者。参与者接受了有效性测试(医疗症状有效性测试;MSVT),并完成了作为神经心理测试一部分的分级症状量表。
共有 23 名参与者(12%)在 MSVT 中失败。失败组报告的脑震荡后症状明显多于通过组,具有较大的效应量(P <.001;d = 1.1)。即使在控制了其他有影响的因素(例如,女性、先前存在的精神问题)后,MSVT 表现仍然是症状报告的一个强有力的独特预测因子。
在 mTBI 后有持续性主诉的儿童中,可能存在夸大或伪装症状的亚组。如果这种负面的反应偏差未被发现,可能会导致病因学陈述中的错误和治疗效果不佳。由于在神经心理学中已经很好地确立了对无效反应的检测,因此临床神经心理学家应该常规地纳入对有持续性主诉的患者的临床护理中。为了在未来的儿科 mTBI 研究中更好地控制非损伤效应,研究人员应该将有效性测试添加到神经行为结果测试中。